These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37760689)

  • 1. Pharmacokinetic, Pharmacokinetic/Pharmacodynamic, and Safety Investigations of Lefamulin in Healthy Chinese Subjects.
    Hu Y; Wei Q; Bian X; Yang X; Yu J; Wang J; Yang H; Cao G; Wu X; Zhang J
    Antibiotics (Basel); 2023 Aug; 12(9):. PubMed ID: 37760689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic/pharmacodynamic target attainment analyses to support intravenous and oral lefamulin dose selection for the treatment of patients with community-acquired bacterial pneumonia.
    Bhavnani SM; Zhang L; Hammel JP; Rubino CM; Bader JC; Sader HS; Gelone SP; Wicha WW; Ambrose PG
    J Antimicrob Chemother; 2019 Apr; 74(Suppl 3):iii35-iii41. PubMed ID: 30949705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerability and Pharmacokinetics of Contezolid at Therapeutic and Supratherapeutic Doses in Healthy Chinese Subjects, and Assessment of Contezolid Dosing Regimens Based on Pharmacokinetic/Pharmacodynamic Analysis.
    Wu J; Wu H; Wang Y; Chen Y; Guo B; Cao G; Wu X; Yu J; Wu J; Zhu D; Guo Y; Yuan H; Hu F; Zhang J
    Clin Ther; 2019 Jun; 41(6):1164-1174.e4. PubMed ID: 31126694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrative population pharmacokinetic/pharmacodynamic analysis of nemonoxacin capsule in Chinese patients with community-acquired pneumonia.
    Chen Y; Wu X; Tsai C; Chang L; Yu J; Cao G; Guo B; Shi Y; Zhu D; Hu F; Yuan J; Liu Y; Zhao X; Zhang Y; Wu J; Zhang J
    Front Pharmacol; 2023; 14():912962. PubMed ID: 36923351
    [No Abstract]   [Full Text] [Related]  

  • 5. Dose adjustment not required for contezolid in patients with moderate hepatic impairment based on pharmacokinetic/pharmacodynamic analysis.
    Wu J; Yang X; Wu J; Wang J; Wu H; Wang Y; Yuan H; Yang H; Wang H; Zhang J
    Front Pharmacol; 2023; 14():1135007. PubMed ID: 36992830
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacokinetics and pharmacodynamics of levofloxacin injection in healthy Chinese volunteers and dosing regimen optimization.
    Cao G; Zhang J; Wu X; Yu J; Chen Y; Ye X; Zhu D; Zhang Y; Guo B; Shi Y
    J Clin Pharm Ther; 2013 Oct; 38(5):394-400. PubMed ID: 23701411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population Pharmacokinetic Modeling Using Polymyxin B Free Plasma Concentrations From Published Reports and Evaluation of Dosage Regimens Based on Monte Carlo Simulation in Critically Ill Patients.
    Zheng Y; Xu B; Chen S; Liu M; Huang H; Wang J; Wu X
    J Clin Pharmacol; 2023 Sep; 63(9):1036-1044. PubMed ID: 37125471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population Pharmacokinetics Study of Contezolid (MRX-I), a Novel Oxazolidinone Antibacterial Agent, in Chinese Patients.
    Li L; Wu H; Chen Y; Yuan H; Wu J; Wu X; Zhang Y; Cao G; Guo B; Wu J; Zhao M; Zhang J
    Clin Ther; 2020 May; 42(5):818-829. PubMed ID: 32389326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and Safety of Single-Dose Amphotericin B Colloidal Dispersion in Healthy Chinese Subjects and Population Pharmacokinetic/Pharmacodynamic Analysis to Inform Clinical Efficacy in Invasive Infections Caused by Candida albicans.
    Huang ZW; Yu JC; Wang JJ; Chen YC; Wu JF; Chen YJ; Cao GY; Yang HJ; He JJ; Dai JY; Zhang JY; Zhang W; Yuan J; Li CL; Xu FY; Wang K; Wu XJ; Zhang J
    Clin Ther; 2021 Nov; 43(11):1921-1933.e7. PubMed ID: 34686365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic evaluation of marbofloxacin after intravenous administration at different ages in llama crias, and pharmacokinetic/pharmacodynamic analysis by Monte Carlo simulation.
    Rubio-Langre S; Aguilar-Sola S; Lorenzutti AM; San Andrés MI; De Lucas JJ; Litterio NJ
    J Vet Pharmacol Ther; 2018 Dec; 41(6):861-870. PubMed ID: 30020535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population pharmacokinetics and pharmacokinetic/pharmacodynamic evaluation of marbofloxacin against Coagulase-negative staphylococci, Staphylococcus aureus and Mycoplasma agalactiae pathogens in goats.
    Serrano-Rodríguez JM; Fernández-Varón E; Rodríguez CMC; Andrés-Larrea MIS; Rubio-Langre S; de la Fe C; Dova SW; Bhardwaj P; Sidhu PK; Litterio NJ; Lorenzutti AM
    Res Vet Sci; 2023 Jun; 159():1-10. PubMed ID: 37060837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of omadacycline regimens for community-acquired bacterial pneumonia patients infected with
    Xu G; Liu X; Wang J; Mei Y; Yang D; He C; Zhong L; Zhu J; Ding H; Fang L
    J Chemother; 2024 Apr; ():1-8. PubMed ID: 38650393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic/Pharmacodynamic Target Attainment of Vancomycin, at Three Reported Infusion Modes, for Methicillin-Resistant
    Song X; Han M
    Front Cell Infect Microbiol; 2022; 12():874401. PubMed ID: 35873144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics, Safety and Pharmacokinetics/Pharmacodynamics Analysis of Omadacycline in Chinese Healthy Subjects.
    Yang H; Huang Z; Chen Y; Zhu Y; Cao G; Wang J; Guo Y; Yu J; Wu J; Liu L; Deng J; Liu J; Reinhart H; Zhang J; Wu X
    Front Pharmacol; 2022; 13():869237. PubMed ID: 35529438
    [No Abstract]   [Full Text] [Related]  

  • 15. Developments in the pharmacokinetic/pharmacodynamic index of linezolid: a step toward dose optimization using Monte Carlo simulation in critically ill patients.
    Dong H; Xie J; Chen L; Wang T; Sun J; Zhao Y; Dong Y
    Int J Infect Dis; 2014 May; 22():35-40. PubMed ID: 24603161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Target attainment of intravenous lefamulin for treatment of acute bacterial skin and skin structure infections.
    van Os W; Zeitlinger M
    J Antimicrob Chemother; 2024 Feb; 79(2):443-446. PubMed ID: 38174805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lefamulin: A Novel Oral and Intravenous Pleuromutilin for the Treatment of Community-Acquired Bacterial Pneumonia.
    Zhanel GG; Deng C; Zelenitsky S; Lawrence CK; Adam HJ; Golden A; Berry L; Schweizer F; Zhanel MA; Irfan N; Bay D; Lagacé-Wiens P; Walkty A; Mandell L; Lynch JP; Karlowsky JA
    Drugs; 2021 Feb; 81(2):233-256. PubMed ID: 33247830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and Pharmacodynamics of Nemonoxacin in a Neutropenic Murine Lung Infection Model Against
    Li X; Chen Y; Xu X; Li Y; Fan Y; Liu X; Bian X; Wu H; Zhao X; Feng M; Guo B; Zhang J
    Front Pharmacol; 2021; 12():658558. PubMed ID: 34017256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and safety of lefamulin after single intravenous dose administration in subjects with impaired-hepatic function.
    Wicha WW; Marbury TC; Dowell JA; Crandon JL; Leister C; Ermer J; Gelone SP
    Pharmacotherapy; 2021 May; 41(5):457-462. PubMed ID: 33811377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of Levornidazole Tablet in Healthy Chinese Subjects and Proposed Dosing Regimen Based on Pharmacokinetic/Pharmacodynamic Analysis.
    Wu H; Wang Z; Wang Y; Yu J; Fan Y; Li Y; Wang J; Cao G; Guo B; Chen Y; Liu X; Bian X; Wu J; Li H; Wu X; Zhang J
    Infect Dis Ther; 2021 Jun; 10(2):911-923. PubMed ID: 33826105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.